ArticleFrontiers in oncology2024

Cost-effectiveness analysis of anlotinib plus chemotherapy with or without benmelstobart versus chemotherapy alone for extensive-stage small-cell lung cancer in China.

Caicong You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.